ClinicalTrials.gov
ClinicalTrials.gov Menu

Rituximab Plus Fludarabine in Treating Patients With Waldenstrom's Macroglobulinemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00020800
Recruitment Status : Completed
First Posted : January 27, 2003
Last Update Posted : January 8, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Jonsson Comprehensive Cancer Center